® Consulta de Marcas Base do INPI · pesquisa e monitoramento

IDSIQ

Registro de marca em vigor (Madri)

Marca Nominativa depositada no INPI em 30/12/2020 por Idorsia Pharmaceuticals Ltd, processo nº 501584862, nas classes 09, 16, 41, 42. Registro em vigor até 30/12/2030.

Número do processo501584862
SituaçãoRegistro de marca em vigor (Madri)
ApresentaçãoNominativa
NaturezaMadri Produto/Serviço
Data do depósito30/12/2020
Data da concessão17/05/2022
Vigência até30/12/2030
TitularIdorsia Pharmaceuticals Ltd
CNPJ/CPF do titular
UF · País— · CH

Classes e especificação

Classe 09 — Software e eletrônicos

Electronic publications (downloadable) in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients.;

Classe 16 — Papelaria e impressos

Printed matter (publications) in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients.;

Classe 41 — Educação e entretenimento

Multimedia publication of printed matter in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; multimedia publication of printed matter in the field of tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients.;

Classe 42 — Tecnologia e pesquisa

Scientific research and development, namely pharmaceutical and medical testing services and development of pharmaceutical and medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; scientific research, namely analysis of objective data on patients by means of diagnostic tests in the context of drug administration, analysis of subjective data on patients by means of patient questioning, analysis of such data with the aim of optimizing drug treatments and drug administration.;

Acompanhe este processo

Receba um e-mail a cada novo despacho publicado na RPI para o processo 501584862 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.

Monitorar esta marca Ver marcas parecidas

Andamento do processo no INPI

3 despacho(s) publicado(s) na Revista da Propriedade Industrial.

  1. 17/05/2022 Concessão de registro em designação código IPAS770 · RPI 2680
  2. 08/02/2022 Deferimento de designação código IPAS768 · RPI 2666
  3. 08/06/2021 Publicação de pedido de registro para oposição (exame formal de designação concluído) código IPAS756 · RPI 2631

Outras marcas de Idorsia Pharmaceuticals Ltd